能(neng)特(te)科技(ji)有(you)限公(gong)(gong)(gong)(gong)司(si)(si)是(shi)上市公(gong)(gong)(gong)(gong)司(si)(si)冠福股份(股票(piao)代碼:002102)全資(zi)控股子公(gong)(gong)(gong)(gong)司(si)(si),成立(li)于2006年,注冊資(zi)本22000萬(wan)元(yuan)。現共(gong)有(you)三個生(sheng)產(chan)(chan)(chan)廠區(qu),生(sheng)產(chan)(chan)(chan)廠區(qu)面(mian)積共(gong)840畝(mu)。公(gong)(gong)(gong)(gong)司(si)(si)現有(you)總(zong)資(zi)產(chan)(chan)(chan)近18億元(yuan),2017年實現銷(xiao)售(shou)收入(ru)9.5 億,員(yuan)工達(da)1000人以(yi)上,各種技(ji)術(shu)人員(yuan)100多名,是(shi)一家以(yi)生(sheng)產(chan)(chan)(chan)、研發(fa)、銷(xiao)售(shou)醫藥中間體及精細化工產(chan)(chan)(chan)品為主的企業。
目前公(gong)(gong)司(si)有(you)兩大產(chan)(chan)品(pin)系(xi)列(lie)(lie)。第一是(shi)醫藥中(zhong)間(jian)體系(xi)列(lie)(lie),以治(zhi)療(liao)(liao)哮喘(chuan)和抗過敏的孟魯司(si)特鈉中(zhong)間(jian)體、治(zhi)療(liao)(liao)高血脂和高膽固醇的瑞(rui)舒伐他汀中(zhong)間(jian)體為(wei)主導產(chan)(chan)品(pin);第二是(shi)以維生(sheng)素(su)E 及其中(zhong)間(jian)體為(wei)起點發展(zhan)的維生(sheng)素(su)系(xi)列(lie)(lie)。公(gong)(gong)司(si)將主導產(chan)(chan)品(pin)發展(zhan)成(cheng)為(wei)全(quan)球產(chan)(chan)能、市場占有(you)率、品(pin)質(zhi)領先的產(chan)(chan)品(pin),形(xing)成(cheng)了企業的核(he)心(xin)競(jing)爭(zheng)力。